RxDoctor Payments DataLook up a doctor →

Nanyoung Park

Adult Health · Duluth, GANPI 1043633084

Payments from drug & device makers

$8,882in general payments, 2019–2025

Across 398 payments — averaging $22.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$700
  • Merck$655
  • Johnson & Johnson$652
  • Novartis$554
  • Bristol Myers Squibb$494
  • Seagen Inc.$424
  • plus $5K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)32$700
Merck23$655
Johnson & Johnson(2 entities)31$652
Novartis26$554
Bristol Myers Squibb23$494
Seagen Inc.22$424
Daiichi Sankyo Inc.17$423
Pfizer25$415
Genentech USA, Inc.14$296
Eisai Inc.10$244
GSK10$243
AbbVie10$243
Astellas Pharma US Inc8$206
Amgen10$179
Incyte Corporation9$172
Beone Medicines USA, Inc.6$149
Stemline Therapeutics Inc.6$141
E.r. Squibb & Sons, L.L.C.7$138
Deciphera Pharmaceuticals Inc.7$136
Ipsen Biopharmaceuticals, Inc5$136
Takeda Pharmaceuticals U.S.A., Inc.4$130
Beigene USA, Inc.6$127
Coherus Oncology, Inc.6$123
Karyopharm Therapeutics Inc.5$109
Novo Nordisk1$107
Pharmacyclics LLC, An Abbvie Company4$105
ADC Therapeutics America, Inc.5$99
Bayer4$91
Exelixis Inc.3$78
Sobi, Inc3$77
Dendreon Pharmaceuticals LLC3$77
Foundation Medicine, Inc.3$69
Puma Biotechnology, Inc.3$67
Sanofi3$66
Regeneron Healthcare Solutions, Inc.3$63
Gilead3$60
AVEO Pharmaceuticals, Inc.2$57
Tempus AI, Inc2$57
Jazz Pharmaceuticals Inc.2$56
Servier Pharmaceuticals LLC3$54
Mirati Therapeutics, Inc.2$52
Array Biopharma Inc3$46
Adaptive Biotechnologies Corporation2$43
Caris MPI, Inc.2$41
Lilly USA, LLC2$38
Tersera Therapeutics LLC2$38
Blueprint Medicines Corporation1$37
Sun Pharmaceutical Industries Inc.1$33
Boehringer Ingelheim1$31
Inari Medical, Inc.1$30
Alnylam Pharmaceuticals Inc.1$27
G1 Therapeutics, Inc.1$22
Myovant Sciences Inc.1$22
Ferring Pharmaceuticals Inc.1$20
Immunogen, Inc.1$19
Exact Sciences1$18
Dova Pharmaceuticals1$17
Morphosys, US Inc.1$16
Myriad Genetic Laboratories, Inc.1$16
Kowa Pharmaceuticals America, Inc.1$15

How this compares

$8,882 in reported general payments places this provider in the 95th percentile of 577 adult health providers in Georgia.

See all adult health providers in Georgia

Medicare billing

Part B allowed, 2024
$19,410
Medicare patients
81
Services billed
290

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Duluth

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →